Trends in the management of hidradenitis suppurativa in the Middle East region: a systematic review.

Please login or register to bookmark this article
Bookmark this %label%

Hidradenitis suppurativa (HS) is a chronic, painful, and severely debilitating inflammatory disease that affects apocrine gland-bearing skin. There is no universal consensus on the management of hidradenitis suppurativa (HS). Current available guidelines are from western countries, which may be of limited use in other parts of the world. In this study, we aim to identify trends in the management of HS in the Middle East (ME) and its differences with the West.A systematic literature review was performed to identify all studies in HS management performed by experts in the ME from database inception to June 2020 using PubMed, EMBASE, and Cochrane Library databases. Only original articles published in English language were included. Guidelines from western countries were used for comparison.Fifty-four eligible studies comprising 7649 HS patients from the ME region and nine guidelines from the West were included. No established guidelines were found for the management of HS in the ME. Sex ratio of HS patients in the ME is different in that men reported to be affected at a higher rate than in the West. Different antibiotic regimens were recommended in the ME, and the experts in the ME tend to be more procedure intensive than experts in the West.Establishing a guideline for HS management in the ME is recommended to address unique considerations in the countries in this region.

View the full article @ International journal of dermatology
Get PDF with LibKey

Authors: Mehran Karvar, Adriana C Panayi, Afsaneh Alavi, Zahra Baziar, Dennis P Orgill